Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO) Syndrome with Henoch–Schönlein Purpura: A Case Report

References

• Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987;54(3):187–196. French.
   PubMedGoogle Scholar
• Norikane T, Yamamoto Y, Arai-Okuda H, et al. Pulmonary vasculitis on dual-phase 18F-FDG PET/CT in SAPHO syndrome. Clin Nucl Med. 2022;47(5):e411–e413. doi:10.1097/RLU.0000000000004104
   PubMed Web of Science ®Google Scholar
• Shanmugam VK, Phillpotts M, Brady T, et al. Retinal vasculitis with chronic recurrent multifocal osteomyelitis: a case report and review of the literature. BMC Rheumatol. 2019;3:29. doi:10.1186/s41927-019-0076-5
   PubMedGoogle Scholar
• Yabe H, Takano Y, Nomura E, et al. Two cases of SAPHO syndrome accompanied by classic features of Behcet’s disease and review of the literature. Clin Rheumatol. 2008;27(1):133–135. doi:10.1007/s10067-007-0697-8
   PubMed Web of Science ®Google Scholar
• Nishiya K, Oosaki F, Nakamura T, et al. Rheumatoid arthritis associated with Henoch-Schönlein purpura. Clin Exp Rheumatol. 2000;18(5):653–654.
   PubMed Web of Science ®Google Scholar
• Beauvais C, Kaplan G, Mougenot B, et al. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis. 1993;52(1):61–62. doi:10.1136/ard.52.1.61
   PubMed Web of Science ®Google Scholar
• Gao S, Deng X, Zhang L, et al. The comparison analysis of clinical and radiological features in SAPHO syndrome. Clin Rheumatol. 2021;40(1):349–357. doi:10.1007/s10067-020-05187-0
   PubMed Web of Science ®Google Scholar
• Sirufo MM, Raggiunti M, Magnanimi LM, et al. Henoch-Schönlein purpura following the first dose of COVID-19 viral vector vaccine: a case report. Vaccines. 2021;9(10):10. doi:10.3390/vaccines9101078
   Web of Science ®Google Scholar
• Li Y, Huo J, Cao Y, et al. Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. Ann Rheum Dis. 2020;79(9):1255–1257. doi:10.1136/annrheumdis-2020-217250
   PubMed Web of Science ®Google Scholar
• Przepiera-Będzak H, Brzosko M. SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review. Adv Dermatol Allergol. 2021;38(6):937–942. doi:10.5114/ada.2020.97394
   PubMed Web of Science ®Google Scholar
• Pillebout E, Sunderkötter C. IgA vasculitis. Semin Immunopathol. 2021;43(5):729–738. doi:10.1007/s00281-021-00874-9
   PubMed Web of Science ®Google Scholar
• Abu-Zaid MH, Salah S, Lotfy HM, et al. Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis. Ther Adv Musculoskel. 2021;13:1759720X–2110596X.
   Web of Science ®Google Scholar
• Sun Y, Li C, Zhu M, et al. Enhanced migration and adhesion of peripheral blood neutrophils from SAPHO patients revealed by RNA-Seq. Orphanet J Rare Dis. 2019;14(1). doi:10.1186/s13023-019-1169-3
   Web of Science ®Google Scholar
• Heineke MH, Ballering AV, Jamin A, et al. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura). Autoimmun Rev. 2017;16(12):1246–1253. doi:10.1016/j.autrev.2017.10.009
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhou Y, Li H-R, Xiong Y-H, Yin W, Zhao L. Characteristics of immune function in the acute phase of Henoch-Schönlein purpura. Clin Rheumatol. 2021;40(9):3711–3716. doi:10.1007/s10067-021-05707-6
   PubMed Web of Science ®Google Scholar
• Xu D, Liu X, Lu C. Reduction of peripheral natural killer cells in patients with SAPHO syndrome. Clin Exp Rheumatol. 2019;37(1):12–18.
   PubMed Web of Science ®Google Scholar
• Jen HY, Chuang YH, Lin SC, et al. Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura. Pediatr Allergy Immunol. 2011;22(8):862–868. doi:10.1111/j.1399-3038.2011.01198.x
   PubMed Web of Science ®Google Scholar
• Firinu D, Barca MP, Lorrai MM, et al. TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome. Autoimmunity. 2014;47(6):389–394. doi:10.3109/08916934.2014.906582
   PubMed Web of Science ®Google Scholar
• Kimura S, Takeuchi S, Soma Y, et al. Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schönlein purpura. Clin Exp Dermatol. 2013;38(7):730–736. doi:10.1111/ced.12089
   PubMed Web of Science ®Google Scholar
• Torres O, Palomino-Morales R, Miranda-Filloy JA, et al. IL-18 gene polymorphisms in Henoch-Schonlein purpura. Clin Exp Rheumatol. 2010;28(1 Suppl 57):114.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Leng X, Luo S, et al. Tolerogenic dendritic cells generated with tofacitinib ameliorate experimental autoimmune encephalomyelitis through modulation of Th17/Treg balance. J Immunol Res. 2016;2016:5021537. doi:10.1155/2016/5021537
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Salama MA, Selima E, et al. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways. Life Sci. 2020;260:118261. doi:10.1016/j.lfs.2020.118261
   PubMed Web of Science ®Google Scholar
• Gratacós Masmitjà J, González Fernández CM, Gómez Castro S, et al. Efficacy of tofacitinib in the treatment of psoriatic arthritis: a systematic review. Adv Ther. 2021;38(2):868–884. doi:10.1007/s12325-020-01585-7
   PubMed Web of Science ®Google Scholar
• Deodhar A, Sliwinska-Stanczyk P, Xu H, et al. Tofacitinib for the treatment of ankylosing spondylitis: a Phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2021;80(8):1004–1013. doi:10.1136/annrheumdis-2020-219601
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhao Y, Li C, et al. Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine. 2018;97(25):e11149. doi:10.1097/MD.0000000000011149
   PubMed Web of Science ®Google Scholar
• Yuan F, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. Front Immunol. 2022;13:911922. doi:10.3389/fimmu.2022.911922
   PubMed Web of Science ®Google Scholar